AJP - Endocrinology and Metabolism, Vol 240, Issue 3 233-E244, Copyright © 1981 by American Physiological Society

ARTICLES

Hepatic metabolism of glucagon in the dog: contribution of the liver to overall metabolic disposal of glucagon

J. B. Jaspan, K. S. Polonsky, M. Lewis, J. Pensler, W. Pugh, A. R. Moossa and A. H. Rubenstein

The hepatic extraction (HE) of glucagon (G) and insulin (I) was measured in 27 dogs, using peripheral infusion of the hormones following elimination of endogenous secretion by pancreatectomy (Px) or somatostatin (S) infusion. HE(G) was 22.5 +/- 1.7%, and HE(I) was 45.1 +/- 3%. HE(G) in seven Px dogs was 27.9 +/- 4.2%, not significantly different from the value of 20.6 +/- 1.6% in 20 S-infused dogs, with corresponding values for HE(I) being 44.9 +/- 6 and 46.0 +/- 3.6%, respectively, suggesting that S does not affect HE of either hormone. HE of endogenous G (22.1 +/- 2.8%) was similar to that of exogenously infused G (19.1 +/- 1.9). HE(G) was nonsaturable in the physiologic and pathophysiologic range of plasma G levels, but there was evidence of saturability in the pharmacologic range. Comparison of simultaneously measured parameters of I and G metabolism indicated independence of the metabolic processes of these two islet hormones, despite distinct similarities in their overall patterns of metabolic disposal. Metabolic clearance rates (MCR) for G and I were 12.6 +/- 0.8 and 19.5 +/- 1.0 ml . kg-1 . min-1, while simultaneously measured hepatic HE rates were 4.2 +/- 0.3 and 8.1 +/- 0.6 ml . kg-1 . min-1, respectively. MCR(G) was independent of arterial G levels. Half-life of infused G and I was 5.5 +/- 0.5 and 4.1 +/- 0.3 min, respectively. The liver accounted for 34.7 +/- 2.4% of the MCR(G) and 42.0 +/- 2.9% of MCR(I). The liver is thus an important site for G removal. However, HE(G) varies widely in different animals, and it is therefore not possible to predict portal vein G concentrations or G secretion rates from G levels in peripheral vessels.

This article has been cited by other articles:

				C. F. Deacon, M. Kelstrup, R. Trebbien, L. Klarskov, M. Olesen, and J. J. Holst Differential regional metabolism of glucagon in anesthetized pigs Am J Physiol Endocrinol Metab, September 1, 2003; 285(3): E552 - E560. [Abstract] [Full Text] [PDF]

				R. H. Coker, L. Simonsen, J. Bulow, D. H. Wasserman, and M. Kjar Stimulation of splanchnic glucose production during exercise in humans contains a glucagon-independent component Am J Physiol Endocrinol Metab, June 1, 2001; 280(6): E918 - E927. [Abstract] [Full Text] [PDF]

				S. A. Hinke, J. A. Pospisilik, H.-U. Demuth, S. Mannhart, K. Kuhn-Wache, T. Hoffmann, E. Nishimura, R. A. Pederson, and C. H. S. McIntosh Dipeptidyl Peptidase IV (DPIV/CD26) Degradation of Glucagon. CHARACTERIZATION OF GLUCAGON DEGRADATION PRODUCTS AND DPIV-RESISTANT ANALOGS J. Biol. Chem., February 11, 2000; 275(6): 3827 - 3834. [Abstract] [Full Text] [PDF]

				R. H. Coker, Y. Koyama, D. B. Lacy, P. E. Williams, N. Rheaume, and D. H. Wasserman Pancreatic innervation is not essential for exercise-induced changes in glucagon and insulin or glucose kinetics Am J Physiol Endocrinol Metab, December 1, 1999; 277(6): E1122 - E1129. [Abstract] [Full Text] [PDF]

				R. H. Coker, D. B. Lacy, M. G. Krishna, and D. H. Wasserman Splanchnic glucagon kinetics in exercising alloxan-diabetic dogs J Appl Physiol, May 1, 1999; 86(5): 1626 - 1631. [Abstract] [Full Text] [PDF]